|
Volumn 4, Issue 4, 1996, Pages 217-243
|
Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritic Research Society
a a a a a a a a a a a a a a a
a
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRHEUMATIC AGENT;
GLUCOCORTICOID;
NONSTEROID ANTIINFLAMMATORY AGENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
OSTEOARTHRITIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PHASE 4 CLINICAL TRIAL;
PRIORITY JOURNAL;
QUALITY OF LIFE;
|
EID: 0029857984
PISSN: 10634584
EISSN: None
Source Type: Journal
DOI: 10.1016/S1063-4584(05)80101-3 Document Type: Conference Paper |
Times cited : (518)
|
References (0)
|